A Multicenter Randomized Controlled Clinical Trial of Bovine Surfactant for Prevention of Respiratory Distress Syndrome
Overview
Affiliations
Treatment with bovine surfactant (SF-RI 1) was shown to be efficacious in improving pulmonary function and in increasing survival rate without BPD in very premature infants. Surfactant therapy did not affect the risk of major complications of prematurity.
Effects of cholesterol on the structure and collapse of DPPC monolayers.
Dayeen F, Brandner B, Martynowycz M, Kucuk K, Foody M, Bu W Biophys J. 2022; 121(18):3533-3541.
PMID: 35841141 PMC: 9515002. DOI: 10.1016/j.bpj.2022.07.007.
Alveolar lipids in pulmonary disease. A review.
Agudelo C, Samaha G, Garcia-Arcos I Lipids Health Dis. 2020; 19(1):122.
PMID: 32493486 PMC: 7268969. DOI: 10.1186/s12944-020-01278-8.
Heljic S, Maksic H, Kalkan I, Krdalic B Bosn J Basic Med Sci. 2009; 9(3):225-8.
PMID: 19754478 PMC: 5632507. DOI: 10.17305/bjbms.2009.2811.
Surfactant replacement therapy.
Kresch M, Lin W, Thrall R Thorax. 1996; 51(11):1137-54.
PMID: 8958900 PMC: 1090528. DOI: 10.1136/thx.51.11.1137.
Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
Halliday H Drugs. 1996; 51(2):226-37.
PMID: 8808165 DOI: 10.2165/00003495-199651020-00004.